Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
Xenon Pharmaceuticals Inc. (XENE) to present at Leerink Partners Global Biopharma Conference 2024 in Miami. Company executives to discuss future plans and strategies.
03/05/2024 - 04:01 PM
VANCOUVER, British Columbia, March 05, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at Leerink Partners Global Biopharma Conference 2024 to be held in Miami, FL on March 11-13, 2024.
Company Fireside Chat Presentation Details:
Date: Monday, March 11, 2024 Time: 11:20 AM Eastern Time Webcast: Register here Presenters: Ian Mortimer, President and Chief Executive Officer Sherry Aulin, Chief Financial Officer
A live webcast of the company presentation will be available on the “Investors ” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (Nasdaq:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. For more information, please visit www.xenon-pharma.com
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.
Contacts: For Investors: investors@xenon-pharma.com
For Media: media@xenon-pharma.com
When will Xenon Pharmaceuticals Inc. (XENE) present at Leerink Partners Global Biopharma Conference 2024?
Xenon Pharmaceuticals Inc. (XENE) will present at Leerink Partners Global Biopharma Conference 2024 on March 11-13, 2024 in Miami, FL.
Who are the presenters from Xenon Pharmaceuticals Inc. (XENE) at the conference?
The presenters from Xenon Pharmaceuticals Inc. (XENE) at the conference are Ian Mortimer, President and Chief Executive Officer, and Sherry Aulin, Chief Financial Officer.
Where can investors watch the live webcast of Xenon Pharmaceuticals Inc. (XENE) presentation?
Investors can watch the live webcast of Xenon Pharmaceuticals Inc. (XENE) presentation on the 'Investors' section of Xenon's website.
Xenon Pharmaceuticals Inc
XENE Rankings
#3064 Ranked by Stock Gains
XENE Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
Canada
City
Burnaby
About XENE
xenon® (nasdaq: xene) is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as extreme genetics. our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits, or phenotypes. we apply our expertise to predict which phenotypes are caused by single-gene defects. by identifying and characterizing the single-gene defects responsible for such severe phenotypes, we gain valuable insights into their function in human biology and their potential as drug targets. given that these targets are often involved in diseases beyond the rare genetic disorders in which they are first identified, we are developing proprietary product candidates to treat both orphan as well as more prevalent diseases.
